# |
View Form |
|
Insider Title |
Company Name |
Ticker |
Trans Type |
Dollar Value |
Shares Traded |
Trans Date From |
Trans Date To |
Trans Price From |
Trans Price To |
Total Holdings |
Delta % Owned |
Owned |
Other Info |
SIC Code |
SIC Sector |
SIC Industry |
SIC Sub-Industry |
Input Date | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
DIR |
AS |
$1,001,218 |
11,487 |
--- |
11/8/24 |
$86.32 |
$89.58 |
443,436 |
-2.5 |
D |
10b |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
11/12/24 - 5:41:56 pm | ||||||||||||||
2 |
DIR |
AS |
$1,000,900 |
10,481 |
--- |
8/2/24 |
$95.20 |
$96.68 |
454,923 |
-2.3 |
D |
10b |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
8/6/24 - 4:30:04 pm | ||||||||||||||
3 |
DIR |
JB |
--- |
2,635 |
--- |
5/9/24 |
--- |
--- |
424,144 |
0.6 |
D |
--- |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
5/13/24 - 5:01:11 pm | ||||||||||||||
4 |
DIR |
AS |
$6,129,889 |
93,863 |
--- |
3/4/24 |
$64.81 |
$66.22 |
251,643 |
-27.2 |
D |
10b |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
3/5/24 - 8:28:43 pm | ||||||||||||||
5 |
DIR |
JB |
--- |
81,169 |
--- |
3/4/24 |
--- |
--- |
345,506 |
30.7 |
D |
10b |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
3/5/24 - 8:28:43 pm | ||||||||||||||
6 |
CEO,DIR |
JS |
--- |
53,350 |
--- |
12/13/23 |
--- |
--- |
264,337 |
-16.8 |
D |
--- |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
12/15/23 - 4:30:13 pm | ||||||||||||||
7 |
CEO,DIR |
AS |
$750,611 |
11,780 |
--- |
11/13/23 |
$63.32 |
$64.12 |
317,687 |
-3.6 |
D |
10b |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
11/15/23 - 4:32:49 pm | ||||||||||||||
8 |
CEO,DIR |
AS |
$750,982 |
10,950 |
--- |
8/11/23 |
$68.22 |
$68.83 |
329,467 |
-3.2 |
D |
10b |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
8/15/23 - 5:35:57 pm | ||||||||||||||
9 |
CEO,DIR |
AS |
$3,592,856 |
44,484 |
--- |
3/27/23 |
$80.47 |
$81.30 |
419,397 |
-9.6 |
D |
A,10b |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
3/29/23 - 9:11:04 pm | ||||||||||||||
10 |
CEO,DIR |
OE |
$850,089 |
44,484 |
--- |
3/27/23 |
--- |
$19.11 |
463,881 |
10.6 |
D |
A,10b |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
3/29/23 - 9:11:04 pm | ||||||||||||||
11 |
CEO,DIR |
OS |
$3,592,856 |
44,484 |
--- |
3/27/23 |
$80.47 |
$81.30 |
419,397 |
-9.6 |
I |
10b |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
3/29/23 - 5:51:32 pm | ||||||||||||||
12 |
CEO,DIR |
OE |
$850,089 |
44,484 |
--- |
3/27/23 |
--- |
$19.11 |
463,881 |
10.6 |
I |
10b |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
3/29/23 - 5:51:32 pm | ||||||||||||||
13 |
PR,CEO,DIR |
AS |
$751,793 |
10,064 |
--- |
3/8/23 |
$74.18 |
$75.29 |
719,397 |
-1.4 |
D |
10b |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
3/10/23 - 5:08:50 pm | ||||||||||||||
14 |
PR,CEO,DIR |
AS |
$6,882,425 |
94,244 |
3/3/23 |
3/6/23 |
$72.90 |
$73.24 |
729,461 |
-11.4 |
D |
R,10b |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
3/6/23 - 9:09:08 pm | ||||||||||||||
15 |
PR,CEO,DIR |
JB |
--- |
151,172 |
3/2/23 |
3/3/23 |
--- |
--- |
823,705 |
22.5 |
D |
R,10b |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
3/6/23 - 9:09:08 pm |
|
|||||||||||||||||||||||||||||
|